KAI Pharmaceuticals Investor Relations Salaries in Boulder | Comparably
KAI Pharmaceuticals discovers and develops novel therapeutics for cardiovascular diseases, kidney diseases and pain. read more
EMPLOYEE
PARTICIPANTS
3
TOTAL
RATINGS
89

KAI Pharmaceuticals Investor Relations Salaries in Boulder

The average KAI Pharmaceuticals Investor Relations in Boulder earns an estimated $59,648 annually. KAI Pharmaceuticals' Investor Relations compensation is $22,282 less than the US average for a Investor Relations.

In Boulder, The Communications Department at KAI Pharmaceuticals earns $7,014 more on average than the Enterprise Risk Department.

Last updated 5 years ago.

$35k
$47k
$63k
$70k
$109k
$139k
$168k
$59,648
Average Compensation
$59,648
avg. base

Investor Relations Salaries at KAI Pharmaceuticals

* estimated salary

Compensation at KAI Pharmaceuticals by Department

In Boulder, The Communications Department averages $7,014 more than the Enterprise Risk Department.

Communications
$191,797 Avg. total comp.
Enterprise Risk
$184,783 Avg. total comp.
-$7k
Product
$150,777 Avg. total comp.
-$41k

Investor Relations Compensation by Gender (All Companies)

The average female Investor Relations at companies similar size to KAI Pharmaceuticals reported making $155,000, while the average male Investor Relations at similar sized companies reported making $50,000.

How Investor Relations at KAI Pharmaceuticals Rate Their Compensation

The majority of Investor Relations at KAI Pharmaceuticals believe they're compensated fairly. 100% of Investor Relations at KAI Pharmaceuticals say they receive annual bonuses, and the majority (50%) are satisfied with their benefits. See more compensation ratings at KAI Pharmaceuticals

×
Rate your company